All Episodes

December 10, 2024 41 mins

Join us for an in-depth discussion about the updated research misconduct final rule.  John Baughman, a research compliance expert, gives an excellent overview of the updates, why they matter, and how to be prepared when the policy goes into effect on January 1, 2025. While we all wait for the templates and guidance documents from the Office of Research Integrity, John provides some excellent advice and breaks down the most important elements of the new final rule.  

Additional Resources: 


Guest Bio: John R. Baumann, Ph.D., was the Associate Vice President for Research Compliance at Indiana University, including the Bloomington and Indianapolis campuses, as well as the five regional campuses and affiliated hospitals. Dr. Baumann has over 25 years of experience in research, research administration, responsible conduct of research, and research compliance. He has had direct-line responsibility for all aspects of research compliance with regulations and ethical standards related to research misconduct, human subjects research, research with animals, conflict of interest, radiation, and biological safety, as well as research development, coordination, and submission of grant and contract applications, and management of funded research.  

Mark as Played

Advertise With Us

Popular Podcasts

24/7 News: The Latest
Stuff You Should Know

Stuff You Should Know

If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.